Breaking News

Tweet TWEET

Astellas Pharma US Receives CEO Cancer Gold Standard Accreditation

  Astellas Pharma US Receives CEO Cancer Gold Standard Accreditation

Business Wire

CARY, N.C. -- October 02, 2012

Astellas Pharma US is leading by example when it comes to promoting workplace
wellness and encouraging healthier behavior. The CEO Roundtable on Cancer
recently accredited Astellas with the CEO Cancer Gold Standard recognizing
their efforts to reduce the risk of cancer for their employees and covered
family members by promoting healthy lifestyle choices, encouraging early
detection through cancer screenings, and ensuring access to quality treatment.

Christopher A. Viehbacher, chief executive officer of Sanofi, chairs the CEO
Roundtable on Cancer, the nonprofit organization of cancer-fighting CEOs who
created the CEO Cancer Gold Standard^™, in collaboration with the National
Cancer Institute, many of its designated cancer centers, and leading health
non-profit organizations and professionals. Today, more than three million
employees and family members are benefiting from the vision and leadership of
the more than 130 employers who have chosen to become Gold Standard
accredited.

“Health care industry leaders see firsthand the benefit that improved
workplace health and wellness can have in cancer prevention and improved
overall health,” said Viehbacher. I hope the leadership and commitment of
Masao Yoshida and the team at Astellas will encourage other employers across
all industries to join them in becoming Gold Standard accredited.”

The CEO Cancer Gold Standard calls for organizations to evaluate their health
benefits and corporate culture and take extensive, concrete actions in five
key areas of health and wellness to fight cancer in the workplace. To earn
Gold Standard accreditation, a company must establish programs to reduce
cancer risk by discouraging tobacco use; encouraging physical activity;
promoting healthy diet and nutrition; detecting cancer at its earliest stages;
and providing access to quality care, including participation in clinical
trials.

"We are honored to be recognized by the CEO Roundtable on Cancer for our
commitment to the health and well-being of our employees, " said Masao
Yoshida, President & CEO of Astellas Pharma US, Inc. "As a company we are
dedicated to improving the health of people around the world by developing
innovative and reliable therapies that allow patients and physicians to take
the next steps in tackling hard-to-treat diseases. Today we are striving to be
at the forefront of the war against cancer and the CEO Cancer Gold Standard
accreditation  further strengthens that commitment.”

In addition to the National Cancer Institute (NCI) and Centers for Disease
Control and Prevention (CDC), fourteen NCI-designated cancer centers and
twenty-five other hospitals and medical centers have earned Gold Standard
accreditation. CEOs from across industries are keenly aware of the tremendous
impact they can have in improving health, controlling health care costs and
making a difference beyond their organization’s walls in the fight against
cancer and other chronic diseases. Other Gold Standard employers include
insurers like Aetna, Cigna, State Farm and several Blue Cross affiliates; law
firms, such as Hogan Lovells and Jenner + Block; technology companies such as
Dell and SAS Institute; and a range of leading employers including American
Century Investments, Johnson & Johnson and Lowe’s.

Astellas Pharma US, Inc., is a U.S. affiliate of Tokyo-based Astellas Pharma
Inc. Located in Northbrook, Illinois, the company serves as the headquarters
for the Americas and employs more than 2,300 people. Astellas is a
pharmaceutical company dedicated to improving the health of people around the
world through the provision of innovative and reliable pharmaceutical
products.

About The CEO Roundtable on Cancer

The CEO Roundtable on Cancer was founded in 2001, when former President George
H.W. Bush challenged a group of executives to "do something bold and
venturesome about cancer within your own corporate families." The CEOs
responded by creating and encouraging the widespread adoption of the CEO
Cancer Gold Standard which calls for organizations to evaluate their health
benefits and workplace culture and take extensive, concrete actions in five
key areas of health and wellness to fight cancer in the workplace. For more
information on the CEO Cancer Gold Standard™ and the web-based accreditation
process and support, please visit www.CancerGoldStandard.org.

About Astellas

The Astellas culture and brand is committed to building community, helping
others, encouraging integrity and inspiring people to make a difference,
today, tomorrow and every day. Astellas Pharma US, Inc., located in
Northbrook, Illinois, is a U.S. affiliate of Tokyo-based Astellas Pharma Inc.
Astellas is a pharmaceutical company dedicated to improving the health of
people around the world through the provision of innovative and reliable
pharmaceutical products. The organization is committed to becoming a global
category leader in focused areas by combining outstanding R&D and marketing
capabilities. For more information about Astellas Pharma US, Inc., please
visit our website at www.astellas.us or follow us on Twitter at
www.Twitter.com/AstellasUS.

Contact:

CEO Roundtable on Cancer
John Dornan, Executive Director
919-531-0966
John.Dornan@CEORoundtableOnCancer.org
 
Press spacebar to pause and continue. Press esc to stop.